Literature DB >> 3489670

Synergy between interleukin-2 and a second factor in the long-term growth of human T cells.

B J Mills, J E Shively, P S Mitsky, D H Hawke, S J Forman, C L Wright, C W Todd.   

Abstract

It has recently been shown that factors in addition to interleukin-2 (IL-2) are required for the proliferation or differentiation of at least some murine T-cell lines. We have previously shown that conditioned medium from human mononuclear cells stimulated with phorbol ester and staphylococcal enterotoxin A is superior to commercial sources of IL-2 for the long-term growth of human T cells. We have identified in these supernatants a non-IL-2 factor (synergistic factor, SF) which synergizes with JURKAT IL-2 in the long-term growth of human T cells. [3H]TdR incorporation by IL-2-dependent human T cells after growth in IL-2 or SF alone for 14 days was slight, but significant. By contrast, growth in a combination of SF and IL-2 for 14 days stimulated [3H]TdR incorporation 10-20-fold higher, generally equal to the high incorporation measured when cells were grown in the presence of the conditioned medium from which SF was obtained. In a standard 2-day IL-2 assay, there was no correlation between activity and long-term growth-promoting ability. These results suggest that the 14-day assay better discerns the growth-promoting activity of various factors or combinations of factors. The mechanism of this interaction between SF and IL-2 remains to be elucidated. It is clear, however, that T-cell growth factor activity, when assessed by the long-term growth of human T cells, is not due to interleukin-2 alone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489670      PMCID: PMC1453126     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

2.  A differentiation factor required for the expression of cytotoxic T-cell function.

Authors:  D H Raulet; M J Bevan
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

3.  The interleukin-2 T-cell system: a new cell growth model.

Authors:  D A Cantrell; K A Smith
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

4.  Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3.

Authors:  A J Hapel; J C Lee; W L Farrar; J N Ihle
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

5.  Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones.

Authors:  M E Andrew; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

6.  Acid treatment enhances IL-2 activity of conditioned medium.

Authors:  B J Mills; P S Mitsky; C W Todd
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

7.  Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines.

Authors:  S E Olabuenaga; C G Brooks; S Gillis; C S Henney
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones.

Authors:  J R Lamb; D D Eckels; P Lake; A H Johnson; R J Hartzman; J N Woody
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Long-term culture of human antigen-specific cytotoxic T-cell lines.

Authors:  S Gillis; P E Baker; F W Ruscetti; K A Smith
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.

Authors:  A L Glasebrook; F W Fitch
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  1 in total

1.  Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.

Authors:  A D Roth; F J Hornicek; C G Gerstner; J M Kirkwood
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.